October 2001

Archives of Physical Medicine and Rehabilitation to Publish CBP® Efficacy Study

By Deed E. Harrison, DC

        Recently, we received notice from the Editor of the Archives of Physical Medicine and Rehabilitation (APM&R) that our clinical control trial on Pope’s cervical 2-way traction had been accepted for publication. Our paper is entitled “New 3-Point Bending Traction Method of Restoring Cervical Lordosis Combined with Cervical Manipulation: Non-randomized Clinical Control Trial” by DE Harrison, R Cailliet, DD Harrison, TJ Janik, and B Holland.

            This study was conducted at my office in Elko, Nevada. We had a treatment group with three-months follow-up with an additional long-term follow-up at 1.5 years and a control group with eight- months follow-up with lateral cervical radiographic analysis. The treatment group had an average of 36 visits at the first follow-up examination. We reported a good percentage of cervical curve improvement.

            Since APM&R is the world’s most prestigious rehabilitation journal, we are very excited to have a CBP® efficacy study on restoring cervical lordosis in this very fine Index Medicus journal. We are probably the first DCs to be published in this journal.

            Judging by our published cervical normal values in SPINE in 1996, our average improvements in cervical lordosis in this present study will support 72-108 visits (i.e., 2 or 3 programs of 36 visits) to restore/rehabilitate a typical patient’s cervical curve. Our CBP® studies are beginning to offset the damage done by IMEs using the Mercy Center Guidelines for acute, uncomplicated, mechanical low back pain (i.e., 12 visits).

            Since we had a cervical curve efficacy study (on compression/extension traction) published in JMPT in 1994, this is our 2nd clinical control trial. We have a 3rd clinical study in review at present and 4 more being written (since data has already been collected and statistical evaluations are being performed). Soon, we at CBP® will have six clinical control trials and one Cohort study published.